New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2014
11:12 EDTCTB, MYGN, AFSIOptions with decreasing implied volatility: CTB AFSI MYGN GREK
News For CTB;AFSI;MYGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 30, 2015
11:32 EDTCTBCooper Tire appoints Brad Hughes COO
Subscribe for More Information
January 29, 2015
09:21 EDTMYGNIridian Asset reports 5.5% passive stake in Myriad Genetics
08:31 EDTMYGNMyriad Genetics guidance at risk, says Morgan Stanley
Subscribe for More Information
January 26, 2015
10:30 EDTAFSIOptions with decreasing implied volatility
Subscribe for More Information
07:17 EDTMYGNSociety of Thoracic Surgeons to hold annual meeting
51st Annual Meeting of STS is being held in San Diego, California on January 24-28.
January 23, 2015
15:46 EDTMYGNPiper Jaffray's medtech analysts hold an analyst/industry conference call
Subscribe for More Information
January 22, 2015
08:04 EDTCTBChinese anti-dumping tariffs positive for tire companies, says Deustche Bank
Subscribe for More Information
07:43 EDTCTBGoodyear rises after U.S. sets dumping margins on Chinese tire makers
The U.S. Department of Commerce announced its affirmative preliminary determination in the antidumping duty investigation of imports of certain passenger vehicle and light truck tires from the People’s Republic of China. Commerce preliminarily determined that imports of certain passenger vehicle and light truck tires from China have been sold in the U.S. at dumping margins ranging from 19.17% to 87.99%. Mandatory respondents Giti Tire Global Trading and Sailun Group received preliminary dumping margins of 19.17% and 36.26%, respectively. All other producers/exporters in China received a preliminary dumping margin of 87.99%. Shares of Goodyear Tire (GT) are up 1.7% in pre-market trading following the determination, while Cooper Tire (CTB) is up 0.7%.
January 20, 2015
07:07 EDTMYGNMyriad RBM joins Institut Pasteur in TB collaboration
Myriad RBM, a wholly owned subsidiary of Myriad Genetics, announced that it will assist the Institut Pasteur in a public-private research collaboration to fight the global tuberculosis, or TB, epidemic. This research project is funded by the Bill & Melinda Gates Foundation through a grant to the Institut Pasteur. The proof-of-concept study will evaluate patients with latent and active TB infections who are affiliated with the South African Tuberculosis Vaccine Initiative clinical study sites. The goals of this study are to field-test Myriad RBM's TruCulture system as a point-of-care blood collection and immune response monitoring method and to stratify patients with active and latent tuberculosis.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use